Donate For Public and Patients Store Search

Welcome!

Search


Here’s looking at you, KID

Keratitis, ichthyosis, and deafness (KID) syndrome is a rare genodermatosis associated with mutations in the GJB2 gene, which encodes connexin 26. Abnormalities of this gap junction protein presumably affects epithelial differentiation, resulting in myriad clinical features.

Session handouts and meetings archive

View previous AAD meeting sessions, handouts, poster exhibits, and floor plans.

A year in review!

From the President ... Dr. Desai served as Academy president from March 2024 to March 2025. ... By Seemal R. Desai, MD, FAAD, December 1, 2024 2024 has certainly been one of the most important years of my entire career. As the year winds down, and we’re set to close

CME & session evaluation archive

Claim CME credit and submit session evaluations for attending previous Academy meetings.

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform.

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

Read the Aug. 17, 2022 DermWorld Insights and Inquiries on cutaneous lupus erythematosus and interferon.

Create your legacy at the AAD - Make a planned gift

Establish your legacy by including the AAD in your will, life insurance, or other estate planning documents.

July 10

Learn more about July 10 at aad.org

Challenges ebb and flow, but our “why” remains the same

From the President ... Dr. Kaufmann served as Academy president from March 2022 to March 2023. ... By Mark Kaufmann, MD, FAAD, March 1, 2023 Serving as your Academy President these last 12 months has been a journey filled with opportunities and challenges. While it has been a test of

It is finally a beautiful day!

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, May 1, 2021 I don’t know about you, but I feel like we are nearing the end of an 18-month winter…I guess spring is good for that, and this May, in particular,

Flimflammers.

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, March 1, 2025 My new favorite word for 2025. As much as I would love to take credit for this perfect word, I must thank our esteemed ... DermWorld Editorial Advisor

Advocacy Update Feb. 4 2025

The AADA is pleased that physician champions in the U.S. House introduced a bipartisan bill to address the 2025 Medicare Physician Fee Schedule cut.

Advocacy Update May 5, 2026

In response to advocacy by the AADA and other specialty societies, UnitedHealth Care will delay any adverse payment decisions related to Medicare Advantage referral requirements starting on May 1.

‘And miles to go before I sleep…’

From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, FAAD, March 1, 2022 Holidays over, now the new year, perhaps an early spring, but unlikely… ... From the streets of Brooklyn to the pinnacle of the specialty —

Taking the challenge: Social media, adolescents, and the skin

Learn more about Taking the challenge: Social media, adolescents, and the skin at aad.org

Advocacy Update Dec 9, 2025

The AADA endorsed a House bill that would include an annual inflationary update to the Medicare physician fee schedule, the Academy’s top federal advocacy priority.

Why we love the Academy.

From the President ... Dr. Cronin served as Academy president from March 2023 to March 2024. ... By Terrence A. Cronin Jr., MD, FAAD, February 1, 2024 We have reached the final full month of the greatest honor of my career: serving you as Academy President. It’s fitting that it

Advocacy Update Feb. 18 2025

The AADA joined over 130 national and state physician organizations led by the AMA demanding Congress act to reform Medicare physician payment.

Advocacy Update Mar. 18, 2025

The AADA is outraged that Congress once again passed a government funding bill that did not include relief to stop this year’s 2.8% Medicare physician payment cut.

Giving thanks.

From the President ... Dr. Cronin served as Academy president from March 2023 to March 2024. ... By Terrence A. Cronin Jr., MD, FAAD, November 1, 2023 As we all begin to prepare for the holidays and start to shore up plans for Thanksgiving, I can’t help but reflect on

Glucose monitors: Not as sweet as they seem

Learn more about Glucose monitors: Not as sweet as they seem at aad.org

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

Read the June 17, 2020 DermWorld Insights and Inquiries on capillary malformation.

Recognizing Trichophyton indotineae

In the last decade, a recently emerged dermatophyte species, Trichophyton indotineae, has been causing major outbreaks of severe, difficult-to-treat, and frequently relapsing infections in South Asia among immunocompetent patients.

Key messages to communicate about Indoor tanning

By communicating these key messages on indoor tanning, you can help position the specialty while increasing your credibility and raising the profile of your practice.

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab

Anifrolumab, a monoclonal antibody that blocks type 1 interferon signaling, has been increasingly reported as an effective treatment in patients with recalcitrant chronic cutaneous lupus erythematosus.

AESOP: The ants and the grasshopper

Dermatologists should consider the diagnosis of AESOP (Adenopathy and Extensive Skin patch Overlying a Plasmactyoma) presented as predominantly truncal erythematous patches or sclerodermoid plaques. A significant number of cases are associated with polyneuropathy and/or POEMS syndrome.

Directions in Residency archive

Access the Directions in Residency archive. Directions in Residency is published each quarter. This archive includes issues going back to 2016. Users can download PDF versions of Directions in Residency.

Biotin supplementation for hair and nail health: Does it pass the test?

Read the November 17, 2021 DermWorld Insights and Inquiries on biotin supplementation for hair and nail health.

After 23 years, a syndrome converted me into an eflornithine believer

Polyamines are integrally involved with the hair cycle. The Bachmann-Bupp syndrome has shed new light on the role of ornithine decarboxylase, and how it’s inhibition by eflornithine can be used as an advantage to either slow or stimulate hair growth.

The nexus of VEXAS syndrome

Read the December 1, 2021 DermWorld Insights and Inquiries on VEXAS syndrome.

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

FcRn antagonists, currently approved for treating myasthenia gravis, show potential for treating pemphigus and other autoimmune diseases.  

Obituaries

Obituaries ... By Jerry Graff, MD, June 1, 2020 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... ROBERT AUERBACH, MD, of New York, Nov. 1, 2017, at age 85. Trained in dermatology at University of Chicago. Was a well-known expert

Recommended reading list

Access this recommended reading list to continue to cultivate your leadership skills. The attached leadership reading list is a vast collection of literature that provides an in-depth look at ways you can meet the challenges of your life and career by enhancing your leadership abilities.

Our donors

The AAD welcomes this year's generous donors and thanks them for their commitment to advancing the programs and services of the Academy.